Alternatives to Pristima

We streamline the intricacies involved in managing your complete product lifecycle. Designed for user-friendliness and flexibility to meet your organization’s specific requirements, STARLIMS lab informatics solutions cater to the evolving demands of data management throughout your organization. Our laboratory information management systems (LIMS software) can seamlessly connect with your existing infrastructure, while also pinpointing areas for process enhancement, enabling you to accelerate the market introduction of high-quality and safe products. In doing so, we empower your organization to thrive in a competitive landscape.

All-in-One LIMS, ELN, QMS, and DMS Platform Xybion LIMS is an all-inclusive Digital Laboratory system including LIMS, ELN, QMS, and DMS that creates optimized workflows for the unique business needs of all regulated laboratories including research, diagnostics, quality control, stability studies, and more. Xybion LIMS instills consistency, improves data quality, and supports regulatory compliance with a complete laboratory management solution that connects with your operating systems with powerful laboratory information management and analytics.

Discover valuable insights within your data by utilizing the Cortellis™ suite of life science intelligence tools, enabling you to make more informed decisions throughout the entire R&D process. We have alleviated the burden of gathering, integrating, and analyzing data, allowing you to concentrate on the essential choices necessary for expediting your products' market entry. With a unique combination of extensive, high-quality data, fortified by profound domain knowledge, industry insight, and therapeutic expertise, Cortellis reveals crucial insights that facilitate data-driven decisions, ultimately speeding up innovation. Access tailored, actionable responses to your specific inquiries throughout the R&D lifecycle, drawing from the most comprehensive and in-depth intelligence sources available. By incorporating Cortellis into your daily routine, you can significantly enhance the pace of innovation and streamline your workflow. This makes Cortellis not just a tool, but a vital partner in your path to success.

Chemia is an innovative ELN platform that operates in the cloud and via browsers, specifically tailored by scientists for their peers. This platform facilitates the management, assignment, monitoring, and documentation of all research and development endeavors from a single intuitive dashboard. It transforms your R&D processes into entirely paperless operations, drastically improving efficiency by saving approximately one hour per scientist through enhanced cross-functional collaboration. Additionally, Chemia ensures that your lab remains audit-ready and manages data with utmost precision. The platform allows for quick retrieval, efficient searching, comparative studies, and reconfigurability, which in turn supports faster and more informed decision-making. Furthermore, Chemia includes an inventory management system that systematically organizes, maintains, and schedules essential information regarding chemicals and equipment utilized in the laboratory. It also offers detailed logs for equipment usage, maintenance, and calibration, which contribute to optimal lab management and productivity. Lastly, the system provides established protocols to ensure compliance with regulatory standards, thereby reinforcing operational integrity.

3decision® serves as a cloud-based repository for protein structures, focusing on efficient management of structural data and offering sophisticated analytics to support teams involved in the discovery of small molecules and biologics, thereby expediting the process of structure-based drug design. The platform consolidates and standardizes both experimental and computational protein structures sourced from publicly available databases such as RCSB PDB and AlphaFoldDB, in addition to proprietary datasets, and accommodates formats like PDBx/mmCIF and ModelCIF. This comprehensive approach guarantees seamless access to a variety of structural formats including X-Ray, NMR, cryo-EM, and modeled structures, thereby promoting collaboration and bolstering research initiatives. In addition to its storage capabilities, 3decision® enhances each entry with valuable metadata and sequence information, which encompasses details on protein-ligand interactions, antibody annotations, and specifics about binding sites. Equipped with advanced analytical instruments, the platform is capable of pinpointing druggable sites, evaluating off-target risks, and facilitating comparisons of binding sites, which collectively transform extensive structural datasets into practical insights that can drive research forward. Furthermore, its cloud-based architecture fosters enhanced collaboration among research teams, making it easier for scientists to share findings and insights, ultimately leading to more innovative approaches in drug discovery and development.

Cytel stands out as a prominent global innovator in software for clinical trial design, biometrics, and advanced analytics, focusing on maximizing the efficiency of clinical trials while aiding pharmaceutical companies in harnessing the full scope of both clinical and real-world data. Established in 1987 by renowned statisticians Cyrus Mehta and Nitin Patel, Cytel has consistently been a leader in adaptive clinical trial technology and the field of biostatistics. Its software solutions, notably the East Horizon platform, facilitate accurate trial design and simulation, employing adaptive and Bayesian methodologies to enhance protocols and expedite the drug development process. The East Horizon platform serves as a comprehensive integration of Cytel's reliable software offerings, featuring R integration that significantly improves trial design functions. Furthermore, Cytel provides the Xact software suite, which is an all-encompassing toolkit designed for statistical analysis of small datasets, including those with sparse and missing data. By continuously innovating and expanding its product offerings, Cytel remains committed to providing cutting-edge solutions that meet the evolving needs of clinical research.

BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.

Scitara DLX™ provides a swift connectivity framework suitable for any instrument found within life science laboratories, all while operating on a cloud-based platform that is both compliant and auditable. As a versatile digital data infrastructure, Scitara DLX™ facilitates connections between various instruments, resources, applications, and software utilized in the lab. The comprehensive cloud system ensures that all data sources are interconnected, promoting seamless data movement across numerous endpoints. Consequently, researchers can concentrate on their scientific endeavors instead of being bogged down by data-related challenges. Moreover, DLX intelligently curates and corrects data as it is processed, fostering the creation of accurate and well-organized data models that are essential for enhancing AI and ML systems. This robust approach plays a vital role in advancing digital transformation strategies within the pharmaceutical and biopharmaceutical sectors. By unlocking valuable insights from scientific data, the platform accelerates decision-making processes in drug discovery and development, ultimately aiding in the expedited launch of new medications into the market. Additionally, the integration of such a sophisticated infrastructure not only streamlines workflows but also enhances collaboration among researchers, paving the way for innovative solutions in the life sciences field.

Rare diseases often lack comprehensive research, resulting in insufficient knowledge about essential elements for an effective drug discovery initiative. Our innovative AI platform, Healnet, addresses these issues by scrutinizing vast amounts of drug and disease data to uncover new connections that may lead to potential treatments. Utilizing cutting-edge technologies throughout the discovery and development process allows us to operate multiple phases simultaneously and on a large scale. The conventional approach of focusing on a single disease, target, and drug is overly simplistic, yet it remains the standard for most pharmaceutical companies. The future of drug discovery is driven by AI, characterized by parallel processes and an absence of rigid hypotheses, fundamentally integrating the three core paradigms of drug discovery into a cohesive strategy. This new paradigm not only enhances efficiency but also fosters creativity in developing solutions for complex health challenges.

To expedite innovative breakthroughs and swiftly bring products to market, research and development alongside manufacturing facilities must adapt and modify their processes in real time. Data management should never become a hindrance in this dynamic landscape. The Thermo Scientific™ Nautilus LIMS™ for Dynamic Discovery and R&D Environments, co-developed with clients operating in rapid R&D contexts, offers a highly adaptable and user-friendly system that enhances workflow efficiency, increases throughput, and ensures data accuracy while streamlining administrative tasks, sample tracking, and adherence to regulatory standards. Its automated management of intricate boards and specialized graphics tools simplifies data oversight, allowing even less experienced users to easily identify and monitor processes. Clients are empowered to design workflows, track the life cycles of samples, and automate interactions across various platforms while seamlessly incorporating regulated protocols that conform to good laboratory practices and the 21 CFR Part 11 regulations. This innovative approach not only fosters a more efficient research environment but also encourages collaboration and creativity among teams.

Streamlined surveillance of diverse data sources, seamlessly integrated with a GVP IX compliant signal management platform, can revolutionize your safety data handling. The Evidex platform offers a ready-to-go, GVP-IX compliant signal management solution that simplifies your operations without the hassle of switching between various services. By modernizing your management processes, you can ensure they are audit-proof and efficient. This automation not only helps meet regulatory standards but also enhances the overall value generated for your organization. With automated signal detection, you can identify safety signals from established sources such as ICSR databases, the FDA's Adverse Event Reporting System (FAERS), VigiBase, and clinical trial data. Furthermore, you can incorporate additional data sources, including claims, electronic health records (EHR), and other unstructured information. By aggregating these diverse data pools, you can significantly improve signaling algorithms, streamline validations and assessments, and accelerate responses to pressing drug safety inquiries. Ultimately, this approach transforms how organizations manage and leverage safety data for better outcomes.

Eidogen-Sertanty's Target Informatics Platform (TIP) stands out as the pioneering structural informatics system and knowledgebase that empowers researchers to explore the druggable genome through a structural lens. By harnessing the burgeoning wealth of experimental protein structure data, TIP revolutionizes structure-based drug discovery, shifting it from a limited, low-throughput field to a dynamic and data-rich scientific discipline. It is specifically designed to connect the realms of bioinformatics and cheminformatics, providing drug discovery scientists with a repository of insights that are not only unique but also highly synergistic with the information available from traditional bio- and cheminformatics tools. The platform's innovative combination of structural data management with advanced target-to-lead calculation and analytical capabilities significantly enhances every phase of the drug discovery process. With TIP, researchers are better equipped to navigate the complexities of drug development and make informed decisions.

Clindata Cloud gathers pre-clinical, clinical, and Risk Metric data from various sources and provides the clinical operations teams with data sets that are ready for submission, along with analytics and alerts for risk-based monitoring. It integrates and harmonizes study data from different origins into a unified data model, ensuring that the incoming data is validated for factors such as completeness, accuracy, integrity, and consistency while also raising alerts for any anomalies or risk indicators. Data is standardized according to CDISC data standards to reduce noise and facilitate the creation of ready-to-submit data sets in real-time, allowing for ongoing validation and analysis. Additionally, it produces real-time analytics based on the standardized data, ensuring timely insights for clinical decision-making. This comprehensive approach enhances the efficiency and reliability of clinical operations.

The in-system protocol serves as a comprehensive training program, integrated with fingerprint attendance for enhanced security. Cronos offers highly customizable workflows tailored for conducting various studies such as dermal, patch, and other bioavailability-bioequivalence (BA-BE) or early-phase research. It enables the capture, cleansing, and efficient management of study data, whether sourced from paper-based or electronic data capture (EDC) trials. Additionally, users can extract data into preferred datasets in compliance with industry standards like CDISC (SDTM). The EDC tool features real-time activity monitoring, and its Bedside Data Collection capabilities facilitate quicker, paperless assessments. Furthermore, Cronos includes a sample inventory and tracking system, ensuring a compliance-ready data repository. It supports data e-printing from nearly all BA instruments and software, along with an online review process complete with e-stamping and e-signatures within a defined workflow. Users can view projects, export, and archive data efficiently while generating high-quality statistical reports, tables, listings, and formats in both fixed and customizable layouts with remarkable ease. This robust system not only streamlines the research process but also enhances overall data integrity and accessibility.

Discngine Assay serves as a comprehensive laboratory informatics platform that unifies all stages of plate-based assays into a streamlined, compliant, and effective workflow, proving to be a vital resource for screening research laboratories. This platform empowers researchers to optimize their entire High Throughput Screening process, encompassing everything from managing samples and analyzing assay data to data storage and qualifying liquid handling instruments. With its user-friendly interface and powerful API, Discngine Assay integrates effortlessly with laboratory equipment and the existing IT infrastructure, facilitating effective data collection and processing. Tailored to expedite the discovery of new molecules, it meets the requirements of the pharmaceutical, biotech, and contract research organization sectors, thereby promoting collaboration and fostering innovation within life sciences research. Furthermore, its ability to adapt to various laboratory environments makes it a versatile solution for evolving research demands.

Why is HORIZON ranked among the top 10 LIMS softwares? HORIZON was designed by lab managers and is an affordable LIMS platform that can be configured and integrated with any type of lab. It is not enough to consider a laboratory information management system an afterthought. It is too important to be forgotten. There is a better option. HORIZON LIMS was designed by and for its users. HORIZON is easily integrated and can be configured to adapt to any lab's existing systems. HORIZON was designed to seamlessly integrate with existing workflows, so there is minimal disruption and fast implementation. HORIZON gives you results that you can see right away. A team of problem solvers supports our intuitive interface. HORIZON was developed by lab professionals. We understand what you need in order to deliver results. HORIZON has expert support and implementation teams that will ensure your system runs smoothly into the future.

Embark on a journey towards enhanced data integrity and assured decision-making with Clinical Ink. As trailblazers in the realm of eSource, their technological framework and service offerings ensure increased reliability from the initial source all the way to submission. Discover Lunexis™, a well-defined and interconnected eSource Ecosystem that provides targeted data capture solutions tailored to your protocol during the pivotal moments that count. The Lunexis platform simplifies the deployment of a cohesive and user-friendly eSource solution, granting you access to your study data anytime and anywhere. We offer more than just rapid and accurate data; we instill assurance in your processes. With this approach, both your sites and patients benefit from a smoother experience, leading to improved patient compliance and engagement, as well as ensuring proper protocol execution. Take the first step toward successfully managing your most intricate studies with confidence — utilize Lunexis to facilitate informed and optimal decision-making for your research endeavors. Moreover, this innovative platform not only streamlines processes but also enhances collaboration among all stakeholders involved in the study.

Historically, managing clinical trials at investigator sites involved either the cumbersome task of maintaining numerous shared spreadsheets or investing in costly software that often did not fit the Australian context. MAISi represents a revolutionary shift in this landscape. Originating in 2001 as a data repository for clinical trials at a prominent hospital, MAISi has transformed into an advanced workflow application designed to streamline various functions within research units. Serving as a centralized database, MAISi efficiently organizes information related to studies and the corresponding business units that manage them. This structured approach enhances management decision-making capabilities. Individual staff members within each business unit can access specific data pertaining to their studies, patients, investigators, and study team members, while those with broader access rights, typically Financial Officers and System Administrators, can view comprehensive data across all units. Additionally, this streamlined access promotes collaboration and improves overall operational efficiency.

Omda MedSciNet solutions enhance the quality, usability, and administration of medical data throughout its lifecycle from collection to analysis. This secure and standardized software streamlines the process for clinical researchers and other professionals in healthcare and academia, allowing for the efficient gathering and examination of well-organized medical data. The dedicated Omda team excels in the development and management of customized database applications, as well as designing clinical studies tailored for medical research and quality registries. The Omda MedSciNet study platform offers a dependable, feature-rich, and highly adaptable online environment suitable for hosting and managing complex study and clinical trial systems. With a proven track record spanning 20 years, Omda MedSciNet has effectively supported studies and clinical trials of various scopes and sizes. Standard implementations come equipped with a comprehensive array of components essential for launching fully functional studies or clinical trials, ensuring that researchers have all the necessary tools at their disposal. This commitment to quality and customization positions Omda MedSciNet as a leader in the field of medical data management.

Discover a comprehensive platform designed for researching, documenting, and organizing your clinical data seamlessly. The Nucleus platform streamlines your research data management, providing a unified space for storing study documentation, clinical datasets, submission materials, and compliant media. With Nucleus Documents, you can efficiently manage documents and maintain version control for your quality documentation and media assets. Easily oversee, manage, and share your organizational content without hassle. Additionally, effortlessly compile and regulate your electronic trial master file documents through our centralized regulatory document management system. Nucleus Coding facilitates dictionary term coding for both MedDRA and WHODrug dictionaries, available as a standalone application or integrated within your data capture system, ensuring flexibility and efficiency in your coding processes. This comprehensive solution not only enhances data integrity but also optimizes collaboration across your research teams.

Dotmatics is the global leader in R&D scientific software that connects science, data, and decision-making. More than 2 million scientists and 10,000 customers trust Dotmatics to accelerate research and help make the world a healthier, cleaner, and safer place to live.

Effectively monitor clinical trials from start to finish with Ennov’s comprehensive Clinical Trial Management software. Each year, clinical trial sponsors search for new ways to improve the efficiency and reduce the costs associated with running their trials. Investigational site efficiency and productivity can be improved by centralizing information, actively monitoring progress, automating schedules, managing finances, and providing accurate reporting and metrics. With the Ennov CTMS, trial sponsors and CROs are able to actively address all aspects of trial management from a single platform: investigator sites, patients, SAEs, deviations, inclusions, visit reports, phone contacts, investigational product management, trial facilities, and finances. Study managers can plan and track their trials in real time to make better decisions faster. With the Ennov CTMS dashboard functionality, study personnel get on-demand analytics to improve quality, control risk, and reduce costs.

When compared to other Electronic Data Capture (EDC) solutions available from companies like MediData, DataTrack, and Omnicomm, TrialStat stands out as the most comprehensive suite of study management tools that can effortlessly integrate with various external data sources, including electronic medical records (EMR), wearable devices, and both clinical and non-clinical information systems. TrialStat presents a cohesive platform that caters to all phases and categories of clinical trials. Our EDC suite is designed with a single sign-on feature and supports multiple tenants, incorporating modules for Randomization, Adjudication, Coding, Safety, Patient Diaries/ePRO, a Vendor Neutral Imaging Archive, an extensive Reporting and Analytics Portal, and tailored Machine Learning applications. With an emphasis on data analysis, TrialStat provides real-time reporting capabilities, on-demand data extracts, and analytics that span a single study, a program, or the entirety of your research portfolio, ensuring that all stakeholders receive pertinent, customized, and timely insights into every facet of study data while pinpointing areas of risk or potential delays. Additionally, the platform’s integration capabilities allow for improved collaboration among research teams, fostering a more efficient and effective trial management experience.

RealTime-CTMS stands out as a leading, cloud-driven clinical trial management system designed specifically to enhance both efficiency and profitability for research sites and site networks. It features a suite of fully-integrated services, such as RealTime-PAY, RealTime-TEXT, and RealTime-eDOCS, which is the first fully-integrated eRegulatory document management system, facilitating faster and easier access to study or subject information through a user-friendly interface. In addition to these offerings, RealTime-CTMS provides a variety of other solutions, including online document storage, appointment reminders, data collection, and payment processing, ensuring comprehensive support for clinical trial management. This extensive array of features makes RealTime-CTMS an invaluable tool for improving the overall workflow within clinical research environments.

To accelerate breakthroughs in health research, it is essential to prioritize the involvement of individuals. This is the motivation behind our platform, which connects people, communities, and researchers through a foundation of trust, transparency, and mutual benefit. Each person's unique health information can provide vital insights that may lead to significant medical advancements, and sharing this data is crucial for discovery. By fostering communities, we can expedite the search for solutions to pressing health issues. Our platform facilitates the collection of health experiences and data from participants throughout various studies, allowing you to begin your research without delay. We harness the power of individual and community health data to tackle some of life’s most urgent challenges. When individuals unite with a shared commitment to responsibility and equity, they create a dynamic force capable of transforming established systems and institutions. Our initiative is driven by a dedicated team of leaders in genomics and technology, committed to making a meaningful impact in healthcare. Together, we can pave the way for innovative solutions that benefit everyone.

BC platforms harnesses cutting-edge scientific advancements, innovative technological capabilities, and strategic alliances to transform drug discovery and tailor healthcare solutions. Our platform is modular and highly adaptable, designed for integrating healthcare data effectively. With an open analytics framework, we seamlessly merge the most recent innovative methods and technology advancements into a single, cohesive platform. We prioritize security, holding ISO 27001 certification alongside compliance with GDPR and HIPAA regulations. Our comprehensive product suite empowers a contemporary healthcare system to fully adopt personalized medicine approaches. Our scalable deployment options support everything from initial setups to expansive healthcare operations. By offering a unique end-to-end toolbox, we facilitate the expedited application of research findings in clinical settings. Moreover, we strive to minimize your risks, enhance the value of your pipeline, and advance your enterprise data strategy by overcoming data access challenges and enabling swift insights. In doing so, we aim to foster a health ecosystem that is both responsive and forward-thinking.

AssisTek stands out as a frontrunner in cutting-edge clinical technology solutions tailored for clinical research, providing specialized software that optimizes and improves the process of gathering patient data. With a legacy of over 25 years, the company has successfully facilitated more than 800 clinical research trials spanning 46 therapeutic areas, which include upwards of 500 multinational Phase I–IV clinical trials. Their electronic Clinical Outcome Assessment (eCOA) solutions boast scalability, customization, and efficiency, backed by a reliable cloud-based technology platform. Among their extensive product offerings are the TEK eCOA Tablet, which accommodates any questionnaire utilized in clinical trials, TEK eDiary, enabling the collection of patient-reported outcomes from home, TEK Configurator for comprehensive project development in clinical trials, and TEK Study Portal, which consolidates eClinical tracking, training, and reporting into one convenient location. AssisTek's innovative systems and services have established them as the preferred partner for data collection and analytics, winning the trust of both patients and healthcare professionals alike. As they continue to evolve, AssisTek remains committed to enhancing the efficiency and accuracy of clinical research methodologies.

Harnessing actionable insights from the leading AI-driven clinical analytics platform allows your teams to effectively manage risk and enhance performance throughout studies, systems, sites, and vendor relationships. The cutting-edge technology from Saama is specifically crafted to optimize workflows, automate labor-intensive tasks, and foster improved collaboration among various clinical functions such as operations, medical review, data management, biostatistics, and pharmacovigilance. Both sponsors and CROs depend on Saama's capabilities for data aggregation and AI solutions, which facilitate superior decision-making, minimize delays, and drastically reduce costs and timelines associated with drug development. By leveraging Saama's tools, you can accelerate the pace of clinical trial innovation. When your clinical data is centralized and continuously updated, it simplifies the lives of your ClinOps and medical review teams considerably. Furthermore, Data Managers, often undervalued, can shift their focus from repetitive tasks to the critical data points that truly drive project success, ensuring that their expertise is fully utilized in the process. This transformation not only enhances efficiency but also contributes to the overall quality of clinical outcomes.

At Metabolon, we proudly provide the most extensive Level 1 library in the metabolomics field. Our unique library has been meticulously developed and refined over two decades, boasting more than 5,400 entries. The majority of these entries are classified as Level 1, comprising roughly 85% (around 4,600 entries); however, about 15% of the library consists of Level 2 entries (approximately 800 entries), which are categorized as such due to the unavailability of commercial standards necessary for Level 1 classification. Thanks to our unparalleled library size and exceptional annotation confidence, Metabolon offers precise and highly actionable insights tailored to our clients’ scientific or clinical needs. The applications of metabolomics span a broad spectrum of research areas, including soil health, nutritional studies, preclinical investigations, and clinical trials. Whether you're identifying trends within a population or fine-tuning an individual's treatment plan, metabolomics serves as a powerful tool to uncover crucial answers to pressing questions in various fields. With such extensive resources at your disposal, the potential for discovery is truly limitless.

ClinOne serves as a comprehensive platform that enhances connectivity and empowerment for participants, caregivers, and clinical trial sites by providing essential tools for trial awareness, consent management, and fostering participant engagement and retention, all supported by robust data analytics and standardized interoperability. Among its many features, Site Hub acts as a centralized resource for trial sites to access vital information, including criteria for participant inclusion and exclusion, site resources, and a streamlined systems landing page equipped with single sign-on capabilities and community engagement options. The Connect module further enriches the experience with features like Sponsor & Monitor Hub, trial awareness initiatives, a healthcare provider community, site selection processes, and data addressing diversity, equity, and inclusion. Meanwhile, the Inform module focuses on facilitating consent management and education through eConsent with eSignature options, as well as offering data insights, tele-visit functionalities, and avenues for community collaboration. Additionally, the Empower module enhances the overall trial experience with services such as transportation management, monitoring medication adherence, and providing a dedicated portal for care partners and caregivers, ensuring a holistic approach to participant support throughout the clinical trial journey.

Data flows in from various channels, including EDC, EHR, smartphones, mobile devices, and central laboratories. Prism expertly integrates this diverse information and transforms it into usable knowledge. By combining user-friendliness with cutting-edge features, Prism EDC presents a modern approach to collecting and managing clinical trial data. Beyond traditional form-based data gathering, Prism also consolidates and organizes information from a wide range of sources. Additionally, Prism eSource offers a groundbreaking software solution that enables research teams to directly pull clinical trial data from a site's electronic health record (EHR). This innovation not only enhances efficiency and reduces costs compared to the existing model—where sites redundantly input the same data into multiple systems—but also speeds up the availability of new therapies to patients in need. As a result, the healthcare industry stands to benefit significantly from the streamlined processes that Prism facilitates.

Experience seamless collaboration and knowledge sharing across your organization with a comprehensive platform that integrates all essential tools, allowing for secure workflows and the use of Phoenix-based applications alongside third-party software. With more than 6,000 researchers relying on Phoenix WinNonlin for non-compartmental analysis (NCA), toxicokinetic modeling, and pharmacokinetic and pharmacodynamic (PK/PD) modeling, it has become the preferred choice among biopharmaceutical companies, academic institutions, and 11 international regulatory bodies, including the US FDA, EMA, and PMDA. Additionally, the Phoenix Platform offers advanced features like population PK/PD (popPK) modeling through Phoenix NLME and Level A correlation capabilities provided by the Phoenix IVIVC Toolkit, while its Validation Suites enable rapid software validation in less than half an hour, ensuring efficiency and compliance. This powerful suite not only enhances research productivity but also fosters innovation by enabling users to streamline their workflows effectively.

A cloud platform that is accessible from anywhere, infinitely scalable, and powered by AI offers collaborative features while adhering to the strictest security and compliance standards. This user-friendly software, designed by specialists in neuroimaging and data science, addresses the specific and complex requirements of the neuroscience field. Customized to suit your particular needs, it supports a wide range of activities, including research, clinical trials, point-of-care applications, algorithm development, and the utilization of brain-related data. The platform facilitates global data aggregation and consolidates imaging studies into a single cloud environment. It provides an efficient, comprehensive management solution for clinical, real-world data, and medical imaging information. Users receive tailored, expert assistance throughout their studies to ensure successful outcomes. Additionally, it features centralized reading capabilities and the option to compare quantitative results against a normative database. The platform also guarantees high-quality, shareable reporting and data export options to streamline the submission approval process, making it an invaluable tool for neuroscience professionals. Furthermore, its innovative design enhances collaboration among researchers and clinicians, fostering a community dedicated to advancing the field.

ClinAccess™ 5.1 represents the evolution of our premier Clinical Data Management System, built entirely on the robust SAS® 9 platform. This innovative system paves the way for streamlined clinical data management, efficient clinical trial analysis, and seamless preparation of electronic submissions. By integrating data entry directly into SAS® data sets, it significantly boosts your team’s efficiency by removing the cumbersome process of transferring data from Oracle/SQL to SAS. ClinAccess™ is specifically tailored for user-friendly study definition, data entry, and management, featuring tools that track the progress and quality of ongoing clinical trials. Your data is consistently maintained in SAS® for easy access, whether for review, analysis, or submission to the FDA. The underlying database architecture is optimized to facilitate rapid statistical analysis and reporting. Consequently, users can expect reduced time and effort in data analysis, ultimately leading to a faster time to market. Additionally, ClinAccess™ stands out for its reliability, comprehensive auditing capabilities, and robust security measures, making it an unparalleled choice for clinical data management. With ClinAccess™, you can confidently navigate the complexities of clinical trials while ensuring data integrity and compliance.

Experience a comprehensive and integrated solution with our Clinical Data Management System (CDMS), Clinical Trial Management System (CTMS), and Electronic Data Capture System (EDC) all combined. With our advanced and adaptable Clinical Trial Software System, all your research information is easily accessible. You have the choice to host Clindex® on your own servers or utilize the Fortress Medical Cloud (SaaS – Software as a Service) for convenience. Global cloud access ensures that your data remains securely housed in a SOC 3 certified data center. Whether you prefer to create your own study database or require assistance, Clindex® equips you with all the necessary tools. Our straightforward quick start manuals and comprehensive help documentation guide you meticulously through the setup process. Alternatively, you can rely on our dedicated Clindex services team to design a study tailored to your needs, ensuring a smooth and efficient experience.

uMotif is an innovative platform for eCOA/ePRO and eConsent, aimed at enhancing both clinical and real-world research efforts. Created with input from patients, this platform offers unmatched engagement, significantly improving the speed, quality, and precision of data collection. Through the integration of uMotif's eCOA/ePRO system with real-time glucose monitoring, the platform achieved remarkable compliance rates during a comprehensive diabetes study across Europe. In another instance, an immunology trial benefited from the patient-focused eCOA/ePRO solution, enabling the sponsor to fulfill data requirements a full six months ahead of schedule. Additionally, in a CNS study mandated by the FDA, participants utilized their personal devices to provide submission-ready ePRO data, showcasing the platform's versatility. uMotif's commitment to a patient-first design philosophy emphasizes a deep understanding of the patient experience and the factors influencing their behavior. This expertise not only ensures the development of software that addresses patient needs effectively but also results in extraordinarily high engagement levels for study sponsors, fostering a win-win environment for both parties.

The integration of eCOA and digital technologies is paving the way for the future of clinical research, seamlessly connecting traditional methods with innovative, patient-centered approaches. Choose YPrime's eCOA solutions to not only obtain high-quality patient data but also to enhance the overall user experience for sponsors, investigator sites, and patients alike. By employing a flexible software development strategy, YPrime is able to swiftly tailor and adapt functionalities to meet specific study requirements within an impressive timeframe of 8 to 12 weeks. Our engaging and visual design process allows clients to review the system at various stages of development, ensuring they are informed before the system goes live. Additionally, our pre-validated and customizable authoring environment not only streamlines startup timelines but also accommodates post-production adjustments, such as changes to study protocols, making it an indispensable asset for clinical research. This commitment to agility and responsiveness positions YPrime as a leader in the evolving landscape of clinical trials.

Catalyst ABA Data Collection. Catalyst can be used to collect and manage a variety of data types. Your Catalyst system can be adjusted to meet your specific needs. Diagnostic information, such antecedents and consequences, locations, times, etc. Topographical behavior data such as frequency, severity and duration.

Research teams are facing rising demands to achieve greater outcomes with limited resources. The progress of a trial can be significantly hindered by issues such as disconnected systems, the necessity for manual data entry, repetitive workflows, and fragmented information. Thus, it is essential to adopt a clinical trial management system that integrates and optimizes workflows while ensuring complete transparency, and Medidata offers the perfect solution. Rave CTMS stands out as the sole data-centric platform designed for efficient and intelligent end-to-end trial management. As a key component of the Medidata Rave Clinical CloudTM, it encompasses all the features you would expect from a top-tier CTMS and even more. Rave CTMS empowers your study teams to plan and oversee all clinical trials consistently and cohesively, standardizing activity planning and management across study, country, and site levels. This includes managing the creation and activation of study/site teams, tracking patient enrollment and milestones, monitoring sites, and addressing issues effectively. Moreover, with Rave CTMS, you can enhance collaboration and communication among team members, which ultimately leads to better trial outcomes.

We provide a range of solutions, from straightforward turnkey options to extensive multi-site research projects, assisting principal investigators in navigating the typical challenges associated with database configuration and selection. Researchers frequently turn to QuesGen for expert guidance on optimal data management practices and for supplementary services that facilitate the swift launch of their studies. As a seasoned collaborator for numerous academic institutions and researchers, we excel in handling sizable datasets and performing data curation through our adaptable data platform. This capability allows for the rapid and seamless initiation and expansion of research projects. With an all-encompassing data model, a library of assessments, and expertise in curation, QuesGen is dedicated to ensuring that you are operational quickly while guaranteeing high-quality, compliant data, enabling you to concentrate on analyzing your findings. Our solutions support various clinical research efforts within your organization, adhering to HIPAA and FDA 21 CFR Part 11 requirements, and they can seamlessly integrate with your electronic medical records system and the Federal Interagency TBI Repository (FITBIR). By leveraging our services, researchers can enhance their efficiency and streamline their workflows, ultimately leading to more impactful research outcomes.

Complion's platform was designed for clinical researchers. Our solution ensures compliance at the highest level with the lowest effort and the most efficiency. This allows you to concentrate on what really matters: improving and advancing patient outcomes. Our eReg solution is available to all clinical trial stakeholders, whether you are a Sponsor, Research Site or CRO. Reduce costs, avoid redundancy and increase staff productivity. You can easily archive, view and get signatures from any device. An audit trail is built into the system to ensure accuracy and eliminate patient safety risks and study conduct. Our clients include hospitals, cancer centers, and medical centers as well as multi-specialty clinics and dedicated research sites.

Clario CTMS offers a user-friendly, comprehensive solution for managing clinical trials, enhancing control and efficiency in both data management and workflow while delivering high-quality data for every study, which ultimately leads to significant savings in time, labor, and operational costs. This cloud-based system allows users to access and oversee real-time operational metrics from anywhere at any time, ensuring flexibility in trial management. By utilizing a Microsoft Office-based work environment, Clario CTMS streamlines fragmented clinical trials into a unified and productive workspace, leveraging the familiarity of the most popular office tools globally. The smooth, bi-directional data transfer between Clario CTMS and SharePoint, along with other Microsoft products, creates a robust and efficient platform. Additionally, merging Office functionalities with clinical workflows helps minimize administrative tasks, decrease back-office documentation, and achieve a notably reduced total cost of ownership for organizations. The integration capabilities of Clario CTMS not only enhance operational efficiency but also foster collaboration among teams working on clinical trials.

Our innovative Smart Protocol system is designed to infuse automation and intelligence into the design of clinical trials using artificial intelligence. This groundbreaking solution is transforming the traditional manual processes that research teams have relied on to create clinical trials. In today’s digital landscape, it is practically impossible for individuals to thoroughly analyze every detail pertinent to a decision. Furthermore, many organizations possess valuable data that often goes untapped, with documents frequently stored in repositories that lack visibility. Consequently, life science companies may find themselves making significant and expensive choices based on insufficient information. Our goal is to transition organizations like yours from a document-centric approach to a more insightful, data-driven methodology. We are redefining the research and planning of clinical trials by eliminating the obstacles that separate data from its end-users. To facilitate this, we gather extensive amounts of trial-related documents from both your resources and the public domain, so you can focus on what truly matters—delivering better outcomes for patients. By streamlining access to critical data, we empower teams to make informed decisions faster and more effectively.

Clinpal stands out as the premier comprehensive clinical research platform specifically designed for virtual, hybrid, and direct-to-patient studies. Patients can access the platform from any location using various devices, ensuring convenience and accessibility. Research teams can harness robust data and analytics throughout the entire duration of the trial, while sites benefit from having all necessary functionalities consolidated into one user-friendly system, thus alleviating their workload. With Clinpal Build, users can utilize an intuitive point-and-click interface that allows Contract Research Organizations (CROs) and others to swiftly and effortlessly define data, forms, and workflows. The platform's Single Platform feature offers complete support for clinical trials, encompassing everything from patient recruitment and data capture to long-term follow-up, with data readily available as needed. Clinpal’s cutting-edge technology is designed to accommodate multiple formats, providing a unified online configuration; by setting it up once, it seamlessly operates for users on browsers, mobile devices, or applications. This innovative approach ensures that researchers and participants alike can engage with clinical trials in a streamlined and efficient manner.

OpenText™ Information Management solutions empower organizations in the life sciences sector to harness data and content insights, enhancing their decision-making and speeding up product development. These tools enable seamless integration, management, and secure sharing of information among individuals, systems, and devices. By utilizing information assets effectively from research and development through to commercialization, organizations can benefit from adaptable cloud-native software that operates in any environment. OpenText for life sciences significantly accelerates the discovery process, facilitating the extraction of actionable insights that foster innovation in the pipeline. Users can convert research papers into electronic lab notebooks through intelligent capture, and uncover valuable insights using text mining techniques. Moreover, the platform allows for the extraction of knowledge hidden within unstructured text of clinical trial reports, study protocols, and findings related to clinical safety and efficiency. It also offers methods to intelligently analyze, categorize, and extract information from clinical trial documents, ultimately minimizing the risk of expensive delays and interruptions in the development process. By effectively utilizing these advanced capabilities, life sciences organizations can significantly enhance their operational efficiency and drive forward their research initiatives.